Skip to search boxSkip to navigationSkip to main content

Sclerostin deficient mice rapidly heal bone defects by activating β-catenin and increasing intramembranous ossification

  • ,
  • Zachary C. Ryan
    ,
  • Lomeli R. Carpio
    ,
  • Sanjeev Kakar
    ,
  • Jennifer J. Westendorf
    ,
  • Rajiv Kumar(corresponding author)
*Corresponding author for this work
  • Mayo Clinic Rochester, MN
    ,
  • Mayo Clinic College of Medicine and Science
Scholary Output:
Contribution to journal
Article
Peer-review

Open access

Abstract

We investigated the influence of the osteocyte protein, sclerostin, on fracture healing by examining the dynamics and mechanisms of repair of single-cortex, stabilized femoral defects in sclerostin knockout (Sost-/-; KO) and sclerostin wild-type (Sost+/+; WT) mice. Fourteen days following generation of bone defects, Sost KO mice had significantly more bone in the healing defect than WT mice. The increase in regenerating bone was due to an increase in the thickness of trabecularized spicules, osteoblast numbers and surfaces within the defect. Enhanced healing of bone defects in Sost KO mice was associated with significantly more activated β-catenin expression than observed in WT mice. The findings were similar to those observed in Axin2-/- mice, in which β-catenin signaling is known to be enhanced to facilitate bone regeneration. Taken together, these data indicate that enhanced β-catenin signaling is present in Sost-/- mice that demonstrate accelerated healing of bone defects, suggesting that modulation of β-catenin signaling in bone could be used to promote fracture repair.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 886-890 (5 pages)

Journal (Volume, Issue Number)

Biochemical and Biophysical Research Communications (Volume 441, Issue 4)

Publication milestones

  • Published - 11/29/2013

Publication status

Published - 11/29/2013

ISSN

0006-291X

Publication IDs

  • Scopus: 84888846084
  • PubMed: 24211207

Publication metrics

Metrics

Scopus
citations
SciVal
FWCI
1.30
SciVal
Author count
6
SciVal
citations
37
SciVal
Paper percentile
90
SciVal
Top percentile
10
Fractional count
1
Fractional count
0.17
Fractional count
5
Fractional count
0.83
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Citation count
45
Captures
29

Funding Details

The NIH ( R01 DE020194 , AR60869 , T32 AR056950 , F32 AR60140 ) a grant from the Dr. Ralph and Marion Falk Foundation and the Mayo Clinic Center for Regenerative Medicine supported this work. The authors thank David Razidlo and Bridget Stensgard for assistance with surgical procedures and mouse colony maintenance, and the Mayo Clinic Biomaterials and Quantitative Histomorphometry Core Laboratory for assistance with histological specimen preparation.
FundersFunding numbers
Dr. Ralph and Marion Falk Foundation
-
NIH
F32 AR60140, T32 AR056950, R01 DE020194
NIAMS
R21AR060869
Department of Immunology, Mayo Clinic College of Medicine, Mayo Clinic
-